Raffles Medical Group $343.8m Revenue
SG's Raffles Medical Group revenue surges to $343.8m in H1
SG's Raffles Medical Group revenue surges to $343.8m in H1
The group’s profits after tax ballooned by as much as 138.4%.
Join the community
Most Read
1. Indonesia bets on stem cell rules to boost longevity care 2. IHH Singapore goes preventive with new Healthspan programme 3. Health ministry unveils homegrown AI model built for patients 4. Australia funds $10.4m RNA lung therapy trials at Monash 5. AI in pharma market to hit $28.6b by 2034 on drug discovery pushResource Center
Partner Events
Event News
Medical Taiwan 2026 closes with $168.7m in business opportunities
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential